Schizoaffective Disorder

  • M. T. Tsuang
  • J. C. Simpson
  • J. A. Fleming
Chapter

Abstract

When we refer to the diagnosis of “schizoaffective disorder,” we think of a disorder which is a mixture of schizophrenic and affective (depressive or manic) symptoms. Efforts to clarify the boundary between schizophrenia and affective disorders have resulted in a number of terms proposed to label such patients, but no single definition has met with widespread acceptance. The inclusion of the term “schizoaffective disorder” in DSM-IV (American Psychiatric Association 1994) has substantially improved the situation and has allowed clinicians and researchers to use consistent definitions. Even with these written criteria, there still remains some controversy as to precisely where schizoaffective disorder falls between the major categories of schizophrenia and affective disorders.

Keywords

Bipolar Disorder Affective Disorder Schizoaffective Disorder Bipolar Affective Disorder Affective Symptom 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abrams R, Taylor MA (1976) Mania and schizo-affective disorder manic type: a comparison. Am J Psychiatry 133: 1145–1147Google Scholar
  2. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DCGoogle Scholar
  3. Andreasen NC, Flaum M, Arndt S et al (1991) Positive and negative symptoms: assessment and validity. In: Marneros A, Andreasen NC, Tsuang MT (eds) Negative versus positive schizophrenia. Springer, Berlin Heidelberg New York, pp 28–51CrossRefGoogle Scholar
  4. Angst J (1986) The course of schizoaffective disorders. In: Marneros A, Tsuang MT (eds) Schizoaffective psychoses. Springer, Berlin Heidelberg New York, pp 63–93CrossRefGoogle Scholar
  5. Angst J, Felder W, Lohmeyer B (1979) Are schizoaffective psychoses heterogeneous? II. Results of a genetic investigation. J Affect Disord 1: 155–165PubMedCrossRefGoogle Scholar
  6. Angst J, Stassen HH, Gross G et al (1990) Suicide in affective and schizoaffective disorders. In: Marneros A, Tsuang MT (eds) Affective and schizoaffective disorders. Springer, Berlin Heidelberg New York, pp 168–185CrossRefGoogle Scholar
  7. Berner P, Lenz G (1986) Definitions of schizoaffective psychosis: mutual concordance and relationship to schizophrenia and affective disorder. In: Marneros A, Tsuang MT (eds) Schizoaffective psychoses. Springer, Berlin Heidelberg New York, pp 31–49CrossRefGoogle Scholar
  8. Berrettini WH, Ferraro TN, Goldin LR et al (1994) Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene. Proc Nat Acad Sci 91: 5918–5921PubMedCrossRefGoogle Scholar
  9. Bertelsen A, Gottesman II (1995) Schizoaffective psychoses: genetical clues to classification. Am J Med Genet Neuropsychiatr Genet 60: 7–11CrossRefGoogle Scholar
  10. Biederman J, Lerner Y, Belmaker RH (1979) Combination of lithium carbonate and haloperidol in schizo-affective disorder. A controlled study. Arch Gen Psychiatry 36: 327–333PubMedCrossRefGoogle Scholar
  11. Blacker D, Tsuang MT (1992) Contested boundaries of bipolar disorder and the limits of categorical diagnosis in psychiatry. Am J Psychiatry 149: 1473–1483PubMedGoogle Scholar
  12. Blehar MC, Faraone SV, Zeller PJ et al (1996) Differentiation of schizoaffective bipolar disorder from bipolar disorder and schizophrenia. Depression 3: 309–315CrossRefGoogle Scholar
  13. Brockington IF, Leff JP (1979) Schizo-affective psychosis: definitions and incidence. Psychol Med 9: 91–99PubMedCrossRefGoogle Scholar
  14. Brockington IF, Kendell RE, Kellet JM et al (1978) Trials of lithium, chlorpromazine and amitriptyline in schizoaffective patients. Br J Psychiatry 133: 162–168PubMedCrossRefGoogle Scholar
  15. Brockington IF, Kendell RE, Wainwright S (1980a) Depressed patients with schizophrenic or paranoid symptoms. Psychol Med 10: 665–675PubMedCrossRefGoogle Scholar
  16. Brockington IF, Wainwright S, Kendell RE (1980b) Manic patients with schizophrenic or paranoid symptoms. Psychol Med 10: 73–83PubMedCrossRefGoogle Scholar
  17. Buda M, Tsuang MT, Fleming JA (1988) Causes of death in DSM-III schizophrenics and other psychotics (atypical group) a comparison with the general population. Arch Gen Psychiatry 45: 283–285PubMedCrossRefGoogle Scholar
  18. Clayton PJ (1982) Schizoaffective disorders. J Nerv Ment Dis 170: 646–650PubMedCrossRefGoogle Scholar
  19. Clayton P, Rodin L, Winokur G (1968) Family history studies. III. Schizoaffective disorder, clinical and genetic factors including a one to two year follow-up. Compr Psychiatry 9: 31–49PubMedCrossRefGoogle Scholar
  20. Coryell W (1986) Schizoaffective and schizophreniform disorders. In: Winokur G, Clayton P (eds) The medical basis of psychiatry. Saunders, Philadelphia, pp 102–114Google Scholar
  21. Coryell W, Lavori P, Endicott J (1984) Outcome in schizoaffective, psychotic, and nonpsychotic depression. Arch Gen Psychiatry 41: 787–791PubMedCrossRefGoogle Scholar
  22. Coryell W, Keller M, Lavori P, Endicott J (1990a) Affective syndromes, psychotic features, and prognosis. I. Depression. Arch Gen Psychiatry 47: 651–657PubMedCrossRefGoogle Scholar
  23. Coryell W, Keller M, Lavori P, Endicott J (1990b) Affective syndromes, psychotic features, and prognosis. II. Mania. Arch Gen Psychiatry 47: 658–662PubMedCrossRefGoogle Scholar
  24. Crow TJ (1980) Molecular pathology of schizophrenia: more than one disease process? Br Med J 280: 66–68PubMedCrossRefGoogle Scholar
  25. Cuesta MJ, Peralta V (1995) Are positive and negative symptoms relevant to cross-sectional diagnosis of schizophrenic and schizoaffective patients? Compr Psychiatry 36: 353–361PubMedCrossRefGoogle Scholar
  26. de Montigny C, Cournoyer G, Morissette R et al (1983) Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression: correlations with neurobiologic actions of tricyclic antidepressant drugs and lithium ion on serotonin system. Arch Gen Psychiatry 40: 1327–1334PubMedCrossRefGoogle Scholar
  27. del Rio Vega JM, Ayuso-Gutierrez JL (1990) Course of schizoaffective psychosis: a retrospective study. Acta Psychiatr Scand 81: 534–537CrossRefGoogle Scholar
  28. Doering S, Muller E, Kopeke W et al (1998) Predictors of relapse and rehospitalization in schizophrenia and schizoaffective disorder. Schizophr Bull 24: 87–98PubMedCrossRefGoogle Scholar
  29. Faraone SV, Matise T, Svrakic D et al (1998) A genome scan of the European-American schizophrenia pedigrees: results from the NIMH Genetics Initiative & Millennium Consortium. Am J Med Genet Neuropsychiatr Genet 81: 290–295CrossRefGoogle Scholar
  30. Fenn HH, Robinson D, Luby V et al (1996) Trends in pharmacotherapy of schizoaffective and bipolar affective disorders: a 5-year naturalistic study. Am J Psychiatry 153: 711–713PubMedGoogle Scholar
  31. Foroud T, Castellucio PF, Koller DL et al (1998) Genomewide scan of affected relative pairs using the NIMH Genetics Initiative bipolar affective disorder pedigrees. Am J Med Genet Neuropsychiatr Genet 81: 462Google Scholar
  32. Fowler RC (1978) Remitting schizophrenia as a variant of affective disorder. Schizophr Bull 4: 68–77PubMedCrossRefGoogle Scholar
  33. Gershon ES, DeLisi LE, Hamovit J et al (1988) A controlled family study of chronic psychoses schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 45: 328–336PubMedCrossRefGoogle Scholar
  34. Ginns EI, Ott J, Egeland JA et al (1996) A genome-wide search for chromosomal loci linked to bipolar affective disorder in the old order Amish. Nature Genet 12: 431–435PubMedCrossRefGoogle Scholar
  35. Goldstein JM, Tsuang MT, Faraone SV (1989) Gender and schizophrenia: implications for understanding the heterogeneity of the illness. Psychiatry Res 28: 243–253PubMedCrossRefGoogle Scholar
  36. Goldstein JM, Faraone SV, Chen WJ, Tsuang MT (1993) The role of gender in understanding the familial transmission of schizoaffective disorder. Br J Psychiatry 163: 763–768PubMedCrossRefGoogle Scholar
  37. Gross G, Huber G, Armbruster B (1986) Schizoaffective psychoses - long-term prognosis and symptomatology. In: Marneros A Tsuang MT (eds) Schizoaffective psychoses. Springer, Berlin Heidelberg New York, pp 188–203CrossRefGoogle Scholar
  38. Grossman LS, Harrow M., Goldberg JF, Fichtner CG (1991) Outcome of schizoaffective disorder at two long-term followups: comparisons with outcome of schizophrenia and affective disorders. Am J Psychiatry 148: 1359–1365PubMedGoogle Scholar
  39. Harrow M, Grossman L (1984) Outcome in schizoaffective disorders: a critical review and reevaluation of the literature. Schizophr Bull 10: 87–108PubMedCrossRefGoogle Scholar
  40. Himmelhoch JM, Fuchs CZ, May SJ et al (1981) When a schizoaffective diagnosis has meaning. J Nerv Ment Dis 169: 277-282PubMedCrossRefGoogle Scholar
  41. Holmboe R, Astrup C (1957) A follow-up study of 255 patients with acute schizophrenia and schizophreniform psychoses. Acta Psychiatr Scand Suppl 115: 9–61Google Scholar
  42. Junginger J, Barker S, Coe D (1992) Mood theme and bizarreness of delusions in schizophrenia and modd psychosis. J Abnorm Psychol 101: 287–292PubMedCrossRefGoogle Scholar
  43. Kant O (1937) Study of a group of recovered schizophrenic patients. Psychiatr Q 15: 262–283CrossRefGoogle Scholar
  44. Kasanin J (1933) The acute schizoaffective psychoses. Am J Psychiatry 90: 97–126Google Scholar
  45. Keck PE, McElroy SL, Strakowski SM (1996) New developments in the pharmacologic treatment of schizoaffective disorder. J Clin Psychiatry 57: 41–48PubMedGoogle Scholar
  46. Kendell RE (1986) The relationship of schizoaffective illnesses to schizophrenic and affective disorders. In: Marneros A, Tsuang MT (eds) Schizoaffective psychoses. Springer, Berlin Heidelberg New York, pp 18–30CrossRefGoogle Scholar
  47. Kendler KS, McGuire M, Gruenberg AM, Walsh D (1995) Examining the validity of DSM-III-R schizoaffective disorder and its putative subtypes in the Roscommon family study. Am J Psychiatry 152: 755–764PubMedGoogle Scholar
  48. Kitamura T, Suga R (1991) Depressive and negative symptoms in major psychiatric disorders. Compr Psychiatry 32: 88–94PubMedCrossRefGoogle Scholar
  49. Kraepelin E (1971) Dementia praecox and paraphrenia. Facsimile of the 1919 edition. Krieger, HuntingtonGoogle Scholar
  50. Kramer MS, Vogel WH, Dijohnson C et al (1989) Antidepressants in ‘depressed’ schizophrenic inpatients. A controlled trial. Arch Gen Psychiatry 46: 922–928PubMedCrossRefGoogle Scholar
  51. Langfeldt G (1939) The schizophreniform states. Munksgaard, CopenhagenGoogle Scholar
  52. Langfeldt G (1956) The prognosis in schizophrenia. Acta Psychiatr Scand Suppl 110: 7–66Google Scholar
  53. Levinson DF, Levitt MEM (1987) Schizoaffective mania reconsidered. Am J Psychiatry 144: 415–425PubMedGoogle Scholar
  54. Levitt JJ, Tsuang MT (1988) The heterogeneity of schizoaffective disorder: implications for treatment. Am J Psychiatry 145: 926–936PubMedGoogle Scholar
  55. Levitt JJ, Tsuang MT (1990) Atypical psychoses. In: Hyman S, Jennike M (eds) Manual of clinical problems in psychiatry. Little Brown, Boston, pp 45–52Google Scholar
  56. Maj M, Perris C (1985) An approach to the diagnosis and classification of schizoaffective disorders for research purposes. Acta Psychiatr Scand 72: 405–413PubMedCrossRefGoogle Scholar
  57. Maj M, Starace F, Kemali D (1987) Prediction of outcome by historical, clinical and biological variables in schizoaffective disorder, depressed type. J Psychiatry Res 21: 289–295CrossRefGoogle Scholar
  58. Manschreck TC, Maher BA, Beaudette SM, Redmond DA (1997) Context memory in schizoaffective and schizophrenic disorder. Schizophr Res 26: 153–161PubMedCrossRefGoogle Scholar
  59. Marneros A, Rohde A, Deister A, Risse A (1986) Schizoaffective disorders: the prognostic value of the affective component. In: Marneros A, Tsuang MT (eds) Schizoaffective psychoses. Springer, Berlin Heidelberg New York, pp 155–163CrossRefGoogle Scholar
  60. Marneros A, Steinmeyer EM, Deister A et al (1989a) Long-term outcome of schizoaffective and schizophrenic disorders: a comparative study. III. Social consequences. Eur Arch Psychiatry Neurol Sci 238: 135–139PubMedCrossRefGoogle Scholar
  61. Marneros A, Rohde A, Deister A (1989b) Unipolar and bipolar schizoaffective disroders: a comparative study. II. Long-term course. Eur Arch Psychiatry Clin Neurosci 239: 164–170Google Scholar
  62. Marneros A, Deister A, Rohde A (1990a) Psychopathological and social status of patients with affective, schizophrenic and schizoaffective disorders after long-term course. Acta Psychiatr Scand 82: 352–358PubMedCrossRefGoogle Scholar
  63. Marneros A, Deister A, Rohde A (1990b) Sociodemographic and premorbid features of schizophrenic, schizoaffective, and affective psychoses. In: Marneros A, Tsuang MT (eds) Affective and schizoaffective disorders. Springer, Berlin Heidelberg New York, pp 130–145CrossRefGoogle Scholar
  64. Marneros A, Deister A, Royde A (1991) Stability of diagnoses in affective, schizoaffective and schizophrenic disorders: crosssectional versus longitudinal diagnosis. Eur Arch Psychiatry Clin Neurosci 241: 187–192PubMedCrossRefGoogle Scholar
  65. Marneros A, Deister A, Rohde A (1992) Comparison of long-term outcome of schizophrenic, affective and schizoaffective disorders. Br J Psychiatry 161: 44–51CrossRefGoogle Scholar
  66. Marneros A, Rohde A, Deister A (1993) Factors influencing the long-term outcome of schizoaffective disorders. Psychopathology 26: 215–224PubMedCrossRefGoogle Scholar
  67. Maziade M, Bissonnette L, Rouillard E et al (1997) 6p24–22 region and major psychoses in the Eastern Quebec population. Am J Med Genet Neuropsychiatr Genet 74: 311–318CrossRefGoogle Scholar
  68. McElroy SL, Dessain EC, Pope HG Jr et al (1991) Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 52: 411–414PubMedGoogle Scholar
  69. McElroy SL, Keck PE Jr, Pope HG et al (1992) Valproate in the treatment of bipolar disorder: literature review and clinical guidelines. J Clin Psychopharmacol 12: 42S-52SPubMedCrossRefGoogle Scholar
  70. McGlashan TH, Williams PV (1990) Predicting outcome in schizoaffective psychosis. J Nerv Ment Dis 178: 518–520PubMedGoogle Scholar
  71. Müller-Oerlinghausen B, Ahrens B, Grof E et al (1992) The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness. Acta Psychiatr Scand 86: 218–222PubMedCrossRefGoogle Scholar
  72. Nelson JC, Mazure CM (1986) Lithium augmentation in psychotic depression refractory to combined drug treatment. Am J Psychiatry 143: 363–366PubMedGoogle Scholar
  73. Okuma T, Yamashita I, Takahashi R et al (1989a) Clinical efficacy of carbamazepine in affective, schizoaffective and schizophrenic disorders. Pharamacopsychiatry 22: 47–53CrossRefGoogle Scholar
  74. Okuma T, Yamashita I, Takahashi R et al (1989b) A double-blind study of adjunctive carbamazepine versus placebo on excited states of schizophrenic and schizoaffective disorders. Acta Psychiatr Scand 80: 250–259PubMedCrossRefGoogle Scholar
  75. Pfohl B, Winokur G (1983) The micropsychopathology of hebephrenic/catatonic schizophrenia. J Nerv Ment Dis 171: 296–300PubMedCrossRefGoogle Scholar
  76. Pope JG Jr, Lipinski J (1978) Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of “schizophrenic” symptoms in the light of current research. Arch Gen Psychiatry 35: 811–828PubMedCrossRefGoogle Scholar
  77. Pope JG Jr, Lipinski JF, Cohen BM, Axelrod DT (1980) Schizoaffective disorder: an invalid diagnosis? A comparison of schizo-affective disorder, schizophrenia and affective disorder. Am J Psychiatry 137: 921–927PubMedGoogle Scholar
  78. Prien RF, Point P, Caffey EMJ, Klett CJ (1972) A comparison of lithium carbonate and chlorpromazine in the treatment of excited schizoaffectives: report of the Veterans Administration and Nation Institute of Mental Health Collaborative Study Group. Arch Gen Psychiatry 27: 182–189PubMedCrossRefGoogle Scholar
  79. Prusoff BA, Williams DH, Weissman MM, Astrachan BM (1979) Treatment of secondary depression in schizophrenia: a double-blind, placebo-controlled trial of amitriptyline added to perphenazine. Arch Gen Psychiatry 36: 569–575PubMedCrossRefGoogle Scholar
  80. Ricca V, Galassi F, La Malfa G et al (1997) Assessment of basic symptoms in schizophrenia, schizoaffective and bipolar disorders. Psychopathology 30: 53–58PubMedCrossRefGoogle Scholar
  81. Rice JP, Goate A, Williams JT et al (1997) Initial genome scan of the NIMH Genetics Initiative bipolar pedigrees: chromosomes 1, 6, 8, 10, and 12. Am J Med Genet Neuropsychiatr Genet 74: 247–253CrossRefGoogle Scholar
  82. Rosenthal NE, Rosenthal LN, Stallone F et al (1980) Toward the validation of RDC schizoaffective disorder. Arch Gen Psychiatry 37: 804–810PubMedCrossRefGoogle Scholar
  83. Samson JA, Simpson JC, Tsuang MT (1988) Outcome studies of schizoaffective disorders. Schizophr Bull 14: 543–554PubMedCrossRefGoogle Scholar
  84. Simpson JC (1988) Mortality studies in schizophrenia. In: Tsuang MT, Simpson JC (eds) Handbook of schizophrenia, vol 3. Nosology, epidemiology and genetics of schizophrenia. Elsevier, Amsterdam, pp 245–273Google Scholar
  85. Siris SG, van Kammen DP, Docherty JP (1978) Use of antidepressant drugs in schizophrenia. Arch Gen Psychiatry 35: 1368–1377PubMedCrossRefGoogle Scholar
  86. Siris SG, Morgan V, Fagerstrom R et al (1987) Adjunctive imipramine in the treatment of postpsychotic depression. Arch Gen Psychiatry 44: 533–539PubMedCrossRefGoogle Scholar
  87. Smeraldi E, Gasperini M, Macciardi F et al (1983) Factors affecting the distribution of age at onset in patients with affective disorders. J Psychiatr Res 17: 309–317CrossRefGoogle Scholar
  88. Spitzer RL, Endicott J, Robins E (1978) Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 35: 773–782PubMedCrossRefGoogle Scholar
  89. Stephens JH, Astrup C, Mangrum JC (1966) Prognostic factors in recovered and deteriorated schizophrenics. Am J Psychiatry 122: 116–1121Google Scholar
  90. Stine OC, Xu J, Koskela R et al (1995) Evidence for linkage of bipolar disorder to chromosome 18 with a parent-of-origin effect. Am J Hum Genet 57: 1384–1394PubMedGoogle Scholar
  91. Taylor MA, Amier N (1994) Are schizophrenia and affective disorder related?: the problem of schizoaffective disorder and the discrimination of the psychoses by signs and symptoms. Compr Psychiatry 35: 420–429PubMedCrossRefGoogle Scholar
  92. Tien AY, Eaton WW (1992) Psychopathologie precursors and sociodemographic risk factors for the schizophrenia syndrome. Arch Gen Psychiatry 49: 37–46PubMedCrossRefGoogle Scholar
  93. Torrey EF (1987) Prevalence studies in schizophrenia. Br J Psychiatry 150: 598–608PubMedCrossRefGoogle Scholar
  94. Tsuang D, Coryell W (1993) An 8-year follow-up of patients with DSM-III-R psychotic depression, schizoaffective disorder, and schizophrenia. Am J Psychiatry 150: 1182–1188PubMedGoogle Scholar
  95. Tsuang MT (1990) Follow-up studies of schizoaffective disorders: a comparison with affective disorders. In: Marneros A, Tsuang MT (ed) Affective and schizoaffective disorders. Springer, Berlin Heidelberg New York, pp 123–129CrossRefGoogle Scholar
  96. Tsuang MT (1991) Morbidity risks of schizophrenia and affective disorders among first-degree relatives of patients with schizoaffective disorders. Br J Psychiatry 158: 165–170PubMedCrossRefGoogle Scholar
  97. Tsuang MT, Dempsey GM, Fleming JA (1979) Can ECT prevent premature death and suicide in “schizoaffective” patients? J Affect Disord 1: 167–171PubMedCrossRefGoogle Scholar
  98. Tsuang MT, Simpson JC, Fleming JA (1986) Diagnostic criteria for subtyping schizoaffective disorder. In: Marneros A, Tsuang MT (eds) Schizoaffective psychoses. Springer, Berlin Heidelberg New York, pp 50–62CrossRefGoogle Scholar
  99. Tsuang MT, Simpson JC, Fleming JA (1992) Epidemiology of suicide. Int Rev Psychiatry 4: 117–129CrossRefGoogle Scholar
  100. Vaillant GE (1964) Prospective prediction of schizophrenic remission. Arch Gen Psychiatry 11: 509–518PubMedCrossRefGoogle Scholar
  101. Welner A, Croughan JL, Robins E (1974) The group of schizoaffective and related psychoses - critique, record, follow-up and family studies. I: A persistent enigma. Arch Gen Psychiatry 31: 628–631PubMedCrossRefGoogle Scholar
  102. Widiger TA, Frances A (1985) The DSM-III personality disorders: perspectives for psychology. Arch Gen Psychiatry 42: 615–623PubMedCrossRefGoogle Scholar
  103. Wildenauer D, Hallmayer J, Albus M et al (1996) A susceptibility locus for affective and schizophrenic disorder? Psychiatr Genet 6: 152CrossRefGoogle Scholar
  104. Zerbin-Rudin E (1986) Schizoaffective and other atypical psychoses: the genetical aspect. In: Marneros A, Tsuang MT (eds) Schizoaffective psychoses. Springer, Berlin Heidelberg New York, pp 225–231CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2001

Authors and Affiliations

  • M. T. Tsuang
  • J. C. Simpson
  • J. A. Fleming

There are no affiliations available

Personalised recommendations